Vaxart, Inc.
VXRT
Revenue
6.40M
▲4.22M▲193.49%
3 Months ChangeAssets
113.75M
▲25.08M▲28.28%
3 Months ChangeLiabilities
33.74M
▲755.00k▲2.29%
3 Months ChangeFree Cash Flow
-21.32M
▲4.38M▲17.03%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-08
Form 8-K
ID: 0001437749-24-030878
2024-09-30
Form 8-K
ID: 0001437749-24-030276
2024-08-08
Form 10-Q
ID: 0001437749-24-025556
2024-08-08
Form 8-K
ID: 0001437749-24-025539
2024-07-05
Form 8-K
ID: 0001437749-24-022250
2024-06-18
Form 8-K
ID: 0001437749-24-020543
2024-06-14
Form 8-K
ID: 0001437749-24-020250
2024-06-13
Form 8-K
ID: 0001437749-24-020215
2024-06-13
Form 8-K
ID: 0001437749-24-020194
2024-05-13
Form 10-Q
ID: 0001437749-24-016236